Lexaria Secures $7.9M, Extends Cash Runway Through 2027
LEXX is trading near its 52-week low of $2.8 (9.6% above the low) on elevated volume (3.0× avg).
Summary
Lexaria added $7.9M from an Australian tax refund and an institutional financing priced at $12.92/share. Management says the cash runway now extends through 2027, with no additional 2026 financings planned. This follows the $5.9M warrant exercise in early September and the AUD$3.67M tax credit received September 1. The financing price is well above the current $3.07 share price, suggesting institutional confidence, though the tiny 2.1M share float means the stock can move sharply. The extended runway reduces near-term dilution risk and gives the company time to advance its R&D pipeline.
At the time of this announcement, LEXX was trading at $3.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.1M. The 52-week trading range was $2.80 to $23.25. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.